| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tvardi Therapeutics, Inc. (TVRD) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. TVRD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 47.5K | $198.6K | - | |
| Other | 17.5K | $73.2K | - | |
| CFO | 17.5K | $73.2K | - | |
| Other | 4.0K | $16.7K | - | |
| 10% | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2020 | Ives Jeffrey L.68 | Director | Sale+OE | 2,500 | $16.00 | $40,000.00 | -29.4% | |
| Feb 3, 2020 | Ives Jeffrey L.68 | Director | Sale+OE | 2,500 | $16.23 | $40,575.00 | -29.4% | |
| Jan 2, 2020 | Chalmers Derek T | President &CEO | Sell | 10,000 | $16.05 | $160,500.00 | -1.1% | |
| Jan 2, 2020 | Ives Jeffrey L.68 | Director | Sale+OE | 2,500 | $16.13 | $40,325.00 | -29.4% | |
| Dec 4, 2019 | Mohindru Mani | CFO &Chief Strategy Officer | Sell | 4,755 | $17.05 | $81,072.75 | -21.4% | |
| Dec 4, 2019 | Chalmers Derek T | President &CEO | Sell | 20,699 | $21.27 | $440,317.95 | -1.1% | |
| Dec 4, 2019 | Terrillion Scott90 | Sec'y; Chief Compliance &G.c. | Sell | 3,980 | $17.05 | $67,859.00 | -19.2% | |
| Dec 2, 2019 | Ives Jeffrey L.68 | Director | Sale+OE | 2,500 | $25.83 | $64,575.00 | -29.4% | |
| Nov 1, 2019 | Chalmers Derek T | President &CEO | Sell | 5,000 | $20.79 | $103,950.00 | -0.5% | |
| Nov 1, 2019 | Ives Jeffrey L.68 | Director | Sale+OE | 2,500 | $20.68 | $51,700.00 | -29.4% |